Combined Peri-operative Lapatinib and Trastuzumab in Early HER2 Positive Breast Cancer can Identify Early Responders: Results from the UK EPHOS-B Trial (CRUK/08/002

View/Open

Supporting information (436.6Kb)

Accepted version (776.9Kb)

ICR Author

Bliss, Judith

Porta, Nuria

Emson, Marie

Author

Bliss, J

Porta, N

Emson, M

Miller, S

Morden, J

Type

Journal Article

Metadata

Show full item record

URI

https://repository.icr.ac.uk/handle/internal/4965

Collections

• Clinical Studies

Research team

Clinical Trials & Statistics Unit

Language

eng

Date accepted

2021-12-20

License start date

2021-12-20

Citation

Clinical Cancer Research

Publisher

American Association for Cancer Research